纽维生物

最新新闻

• Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  B. Riley Securities Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• 评级变动
  RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/21
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)
  TipRanks · 2026/5/27
• Citi Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  Cantor Fitzgerald Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• Citi Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  J.P. Morgan Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)
  TipRanks · 2026/9/15
• 评级变动
  H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• 评级变动
  TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/2

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。